Differences between men and women with respect to colorectal cancer mortality despite screening colonoscopy.


Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
04 Jan 2024
Historique:
received: 13 04 2023
revised: 26 10 2023
accepted: 01 01 2024
medline: 7 1 2024
pubmed: 7 1 2024
entrez: 6 1 2024
Statut: aheadofprint

Résumé

Women aged 55 to 59 years have a similar prevalence rate and number needed to screen for colorectal adenomas as men at a ten years younger age. The aim of this study was to determine sex specific differences in colorectal cancer mortality and estimate the association with adenomas at screening colonoscopy. This retrospective study analyzed 323,139 individuals who underwent colonoscopy within a national colorectal cancer screening program in Austria between 01/2007 and 12/2020. Median age was (60 years [IQR 54-67]) and sex distribution in all age groups was nearly identical. Men had significantly higher odds to have an adenoma or serrated polyp, low risk polyps, high-risk polyps, or colorectal cancer detected at colonoscopy than women (OR 1.83 [1.80-1.86], OR 1.46 [1.44-1.49], OR 1.74 [1.69-1.80], and OR 1.87 [1.70-2.05] respectively). Strikingly, male sex, when compared to female sex, was associated with an almost 2-fold (HR 1.67 [1.05-2.67]) increased risk to die from colorectal cancer when an adenoma or serrated polyp, and a 4-fold (HR 4.14 [2.72-6.3]) increased risk when a high-risk polyp was found at the screening colonoscopy. The cumulative incidence for death of colorectal cancer for 60-year-old individuals was 8.5-fold higher in men as compared to women. Markedly, this gender gap narrowed with increasing age while the difference in deaths of other causes remained similar in all age groups. Our findings strengthen the necessity of sex specific screening recommendations. Importantly, further prospective studies should focus on sex difference in tumor biology to propose personalized surveillance guidelines.

Sections du résumé

BACKGROUND AND STUDY AIMS OBJECTIVE
Women aged 55 to 59 years have a similar prevalence rate and number needed to screen for colorectal adenomas as men at a ten years younger age. The aim of this study was to determine sex specific differences in colorectal cancer mortality and estimate the association with adenomas at screening colonoscopy.
METHODS METHODS
This retrospective study analyzed 323,139 individuals who underwent colonoscopy within a national colorectal cancer screening program in Austria between 01/2007 and 12/2020.
RESULTS RESULTS
Median age was (60 years [IQR 54-67]) and sex distribution in all age groups was nearly identical. Men had significantly higher odds to have an adenoma or serrated polyp, low risk polyps, high-risk polyps, or colorectal cancer detected at colonoscopy than women (OR 1.83 [1.80-1.86], OR 1.46 [1.44-1.49], OR 1.74 [1.69-1.80], and OR 1.87 [1.70-2.05] respectively). Strikingly, male sex, when compared to female sex, was associated with an almost 2-fold (HR 1.67 [1.05-2.67]) increased risk to die from colorectal cancer when an adenoma or serrated polyp, and a 4-fold (HR 4.14 [2.72-6.3]) increased risk when a high-risk polyp was found at the screening colonoscopy. The cumulative incidence for death of colorectal cancer for 60-year-old individuals was 8.5-fold higher in men as compared to women. Markedly, this gender gap narrowed with increasing age while the difference in deaths of other causes remained similar in all age groups.
CONCLUSION CONCLUSIONS
Our findings strengthen the necessity of sex specific screening recommendations. Importantly, further prospective studies should focus on sex difference in tumor biology to propose personalized surveillance guidelines.

Identifiants

pubmed: 38184115
pii: S0016-5107(24)00002-6
doi: 10.1016/j.gie.2024.01.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Auteurs

Elisabeth Waldmann (E)

Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III, Medical University of Vienna; Quality certificate for screening colonoscopy, Austrian Society for Gastroenterology and Hepatology.

Lena Jiricka (L)

Dept. of Clinical Biometrics, Medical University of Vienna.

Jasmin Zessner-Spitzenberg (J)

Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III, Medical University of Vienna; Quality certificate for screening colonoscopy, Austrian Society for Gastroenterology and Hepatology.

Barbara Majcher (B)

Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III, Medical University of Vienna; Quality certificate for screening colonoscopy, Austrian Society for Gastroenterology and Hepatology.

Lisa-Maria Rockenbauer (LM)

Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III, Medical University of Vienna; Quality certificate for screening colonoscopy, Austrian Society for Gastroenterology and Hepatology.

Daniela Penz (D)

Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III, Medical University of Vienna; Quality certificate for screening colonoscopy, Austrian Society for Gastroenterology and Hepatology.

Anna Hinterberger (A)

Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III, Medical University of Vienna; Quality certificate for screening colonoscopy, Austrian Society for Gastroenterology and Hepatology.

Michael Trauner (M)

Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III, Medical University of Vienna; Quality certificate for screening colonoscopy, Austrian Society for Gastroenterology and Hepatology.

Monika Ferlitsch (M)

Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III, Medical University of Vienna; Quality certificate for screening colonoscopy, Austrian Society for Gastroenterology and Hepatology.

Classifications MeSH